News & Stories
The stories of the Faculty of Arts and Sciences: the achievements and activities of our faculty, departments, and programs.
Search & Filter
Applied Filters:
-
In a Q&A, geochemist Gabby Kitch talks about an innovative Yale Center for Natural Carbon Capture project—based in part on science conducted by faculty in the Department for Earth and Planetary Sciences—that will accelerate the oceans’ natural ability to store carbon dioxide.
-
Basu, William K. Lanman Jr. Professor of Astronomy, speaks with a panel of guests about the role of our sun in human history and what the future holds for our nearest star.
-
Faced with a microbial mystery hidden deep in the soil, Nikhil Malvankar—Associate Professor of Molecular Biophysics and Biochemistry—returned to his roots in physics, with results that could shape the field of quantum computing.
-
In a new study, Yale researchers in the lab of Thomas Near, Professor of Ecology and Evolutionary Biology, used genomic analysis to show when cavefishes lost their eyes, which provides a method for dating cave systems.
-
James Mayer and Scott Miller are winners of American Chemical Society awards for physical organic chemistry and creative catalysis.
-
De La Cruz will serve a three-year term beginning February 2026.
-
Eric Arsenault, whose research focuses on developing and applying ultrafast spectroscopies to understand the dynamics of complex nanoscale systems, has been appointed Assistant Professor of Chemistry.
-
Yale researchers have created a new method to predict key periods of gene activity in the developing brain — an advance that may open the door to better targeted genetic therapies.
-
Crews, John C. Malone Professor of Molecular, Cellular, and Developmental Biology, was one of nine awardees recognized for outstanding, translationally focused research projects that aim to accelerate novel diagnostics, therapeutics, vaccines and technological innovations in autoimmunity.
-
Yale researchers led by Ailong Ke, Professor of Molecular Biophysics and Biochemistry, have created a new RNA editing tool that can take some of the risk out of gene therapy.